BetterLife Pharma Inc. SEC filings BETRF

BetterLife Pharma Inc. has 244 filings in SEC EDGAR's recent list, going back to Aug 7, 2009. Its latest annual report, Form 20-F, was filed on Jun 1, 2026 for the period ended Jan 31, 2026. The latest quarterly report (Form 10-Q) was filed on Jun 17, 2019, covering the quarter ended Apr 30, 2019. The most recent current report (Form 6-K) was filed on Sep 30, 2026. The company's fiscal year ends on January 31.

BetterLife Pharma Inc. SEC filings
Form Description Filed Period
6-K Current report (foreign issuer) Sep 30, 2026 Sep 29, 2026
6-K Current report (foreign issuer) Sep 15, 2026 Sep 14, 2026
6-K Current report (foreign issuer) Sep 11, 2026 Sep 11, 2026
6-K Current report (foreign issuer) Aug 24, 2026 Aug 24, 2026
6-K Current report (foreign issuer) Aug 5, 2026 Aug 3, 2026
6-K Current report (foreign issuer) Jun 26, 2026 Apr 30, 2026
6-K Current report (foreign issuer) Jun 25, 2026 Jun 25, 2026
6-K Current report (foreign issuer) Apr 13, 2026 Apr 13, 2026
6-K Current report (foreign issuer) Sep 29, 2025 Sep 26, 2025
6-K Current report (foreign issuer) Jul 28, 2025 Jul 28, 2025
6-K Current report (foreign issuer) Jun 27, 2025 Apr 30, 2025
6-K Current report (foreign issuer) Jun 23, 2025 Jun 23, 2025
6-K Current report (foreign issuer) May 30, 2025 May 29, 2025
6-K Current report (foreign issuer) May 7, 2025 May 6, 2025
6-K Current report (foreign issuer) Apr 7, 2025 Apr 7, 2025
6-K Current report (foreign issuer) Dec 31, 2024 Oct 31, 2024
6-K Current report (foreign issuer) Dec 9, 2024 Dec 9, 2024
6-K Current report (foreign issuer) Oct 15, 2024 Oct 15, 2024
6-K Current report (foreign issuer) Sep 26, 2024 Jul 31, 2024
6-K Current report (foreign issuer) Aug 29, 2024 Aug 29, 2024
6-K Current report (foreign issuer) Aug 8, 2024 Aug 7, 2024
6-K Current report (foreign issuer) Jul 15, 2024 Jul 15, 2024
6-K Current report (foreign issuer) Jun 28, 2024 Apr 30, 2024
6-K Current report (foreign issuer) Jun 17, 2024 Jun 17, 2024
6-K Current report (foreign issuer) May 14, 2024 May 24, 2024
6-K Current report (foreign issuer) May 6, 2024 May 3, 2024
6-K Current report (foreign issuer) Apr 11, 2024 Apr 11, 2024
6-K Current report (foreign issuer) Apr 4, 2024 Apr 4, 2024
6-K Current report (foreign issuer) Mar 5, 2024 Mar 5, 2024
6-K Current report (foreign issuer) Jan 2, 2024 Jan 2, 2024
6-K Current report (foreign issuer) Dec 29, 2023 Oct 31, 2023
6-K Current report (foreign issuer) Dec 18, 2023 Dec 18, 2023
6-K Current report (foreign issuer) Nov 30, 2023 Nov 30, 2023
6-K Current report (foreign issuer) Sep 29, 2023 Sep 29, 2023
6-K Current report (foreign issuer) Sep 28, 2023 Jul 31, 2023
6-K Current report (foreign issuer) Sep 5, 2023 Sep 5, 2023
6-K Current report (foreign issuer) Jul 13, 2023 Jul 13, 2023
6-K Current report (foreign issuer) Jun 28, 2023 Jun 27, 2023
6-K Current report (foreign issuer) Jun 28, 2023 Apr 30, 2023
6-K Current report (foreign issuer) Jun 9, 2023 Jun 9, 2023
6-K Current report (foreign issuer) May 10, 2023 May 10, 2023
6-K Current report (foreign issuer) Apr 25, 2023 Apr 25, 2023
6-K Current report (foreign issuer) Mar 14, 2023 Mar 14, 2023
6-K Current report (foreign issuer) Mar 8, 2023 Mar 8, 2023
6-K Current report (foreign issuer) Mar 7, 2023 Mar 7, 2023
6-K Current report (foreign issuer) Feb 28, 2023 Feb 28, 2023
6-K Current report (foreign issuer) Jan 18, 2023 Jan 17, 2023
6-K Current report (foreign issuer) Dec 23, 2022 Oct 31, 2022
6-K Current report (foreign issuer) Dec 8, 2022 Dec 7, 2022
6-K Current report (foreign issuer) Nov 8, 2022 Nov 7, 2022
6-K Current report (foreign issuer) Sep 27, 2022 Jul 31, 2022
6-K Current report (foreign issuer) Jul 12, 2022 Jul 12, 2022
6-K Current report (foreign issuer) Jun 29, 2022 Apr 30, 2022
6-K Current report (foreign issuer) Apr 6, 2022 Apr 6, 2022
6-K Current report (foreign issuer) Mar 4, 2022 Mar 4, 2022
6-K Current report (foreign issuer) Jan 20, 2022 Jan 20, 2022
6-K Current report (foreign issuer) Dec 23, 2021 Dec 23, 2021
6-K Current report (foreign issuer) Dec 16, 2021 Oct 31, 2021
6-K Current report (foreign issuer) Dec 15, 2021 Dec 15, 2021
6-K Current report (foreign issuer) Dec 9, 2021 Dec 9, 2021
6-K Current report (foreign issuer) Nov 23, 2021 Nov 23, 2021
6-K Current report (foreign issuer) Nov 16, 2021 Nov 16, 2021
6-K Current report (foreign issuer) Oct 20, 2021 Oct 20, 2021
6-K Current report (foreign issuer) Sep 29, 2021 Sep 29, 2021
6-K Current report (foreign issuer) Sep 24, 2021 Jul 31, 2021
6-K Current report (foreign issuer) Sep 21, 2021 Sep 20, 2021
6-K Current report (foreign issuer) Aug 3, 2021 Aug 3, 2021
6-K Current report (foreign issuer) Jul 16, 2021 Jul 16, 2021
6-K Current report (foreign issuer) Jun 29, 2021 Jun 28, 2021
6-K Current report (foreign issuer) Jun 25, 2021 Jun 25, 2021
6-K Current report (foreign issuer) Jun 7, 2021 Jun 7, 2021
6-K Current report (foreign issuer) Jun 7, 2021 May 31, 2021
6-K Current report (foreign issuer) May 28, 2021 May 28, 2021
6-K Current report (foreign issuer) May 21, 2021 May 20, 2021
6-K Current report (foreign issuer) May 17, 2021 May 14, 2021
6-K Current report (foreign issuer) May 5, 2021 May 4, 2021
6-K Current report (foreign issuer) Apr 27, 2021 Oct 31, 2020
6-K Current report (foreign issuer) Apr 20, 2021 Apr 20, 2021
6-K Current report (foreign issuer) Apr 1, 2021 Mar 31, 2021
6-K Current report (foreign issuer) Mar 16, 2021 Mar 16, 2021
6-K Current report (foreign issuer) Mar 15, 2021 Mar 15, 2021
6-K Current report (foreign issuer) Mar 8, 2021 Mar 8, 2021
6-K Current report (foreign issuer) Feb 2, 2021 Feb 2, 2021
6-K Current report (foreign issuer) Jan 19, 2021 Jan 19, 2021
6-K Current report (foreign issuer) Dec 31, 2020 Oct 31, 2020
6-K Current report (foreign issuer) Dec 29, 2020 Dec 29, 2020
6-K Current report (foreign issuer) Dec 22, 2020 Dec 21, 2020
6-K Current report (foreign issuer) Dec 8, 2020 Dec 8, 2020
6-K Current report (foreign issuer) Dec 2, 2020 Dec 2, 2020
6-K Current report (foreign issuer) Nov 23, 2020 Nov 23, 2020
6-K Current report (foreign issuer) Oct 20, 2020 Oct 19, 2020
6-K Current report (foreign issuer) Oct 9, 2020 Oct 8, 2020
6-K Current report (foreign issuer) Sep 29, 2020 Jul 31, 2020
6-K Current report (foreign issuer) Sep 9, 2020 Sep 9, 2020
6-K/A Form 6-k/a Aug 18, 2020 Apr 30, 2020
6-K Current report (foreign issuer) Aug 11, 2020 Aug 11, 2020
6-K Current report (foreign issuer) Jul 31, 2020 Jul 30, 2020
6-K Current report (foreign issuer) Jun 29, 2020 Apr 30, 2020
6-K Current report (foreign issuer) Jun 29, 2020 Jun 29, 2020
6-K Current report (foreign issuer) Jun 15, 2020 Jun 15, 2020
6-K Current report (foreign issuer) Jun 9, 2020 Jun 9, 2020
6-K Current report (foreign issuer) May 26, 2020 May 26, 2020
6-K Current report (foreign issuer) May 13, 2020 May 13, 2020
6-K Current report (foreign issuer) Apr 8, 2020 Apr 7, 2020
6-K Current report (foreign issuer) Jan 23, 2020 Jan 22, 2020
6-K Current report (foreign issuer) Jan 6, 2020 Jan 6, 2020
6-K Current report (foreign issuer) Dec 26, 2019 Oct 31, 2019
6-K Current report (foreign issuer) Dec 5, 2019 Dec 5, 2019
6-K Current report (foreign issuer) Dec 3, 2019 Dec 3, 2019
6-K Current report (foreign issuer) Oct 8, 2019 Oct 8, 2019
6-K Current report (foreign issuer) Oct 1, 2019 Sep 30, 2019
6-K Current report (foreign issuer) Sep 9, 2019 Sep 6, 2019
8-K Current report
Unregistered share sale
May 21, 2019 May 21, 2019
8-K Current report
Unregistered share sale, Auditor change
Feb 4, 2019 Jan 29, 2019
8-K Current report
Material agreement
Dec 19, 2018 Dec 19, 2018
8-K Current report
Unregistered share sale
Nov 6, 2018 Nov 6, 2018
8-K Current report
Unregistered share sale, Officer or director change
Sep 18, 2018 Sep 18, 2018
8-K/A Amended current report
Acquisition or sale of assets, Unregistered share sale
May 16, 2018 May 16, 2018
8-K Current report
Acquisition or sale of assets, Unregistered share sale
Mar 12, 2018 Mar 12, 2018
8-K Current report
Unregistered share sale
Dec 19, 2017 Dec 19, 2017
8-K Current report
Material agreement, Officer or director change
Sep 13, 2017 Sep 12, 2017
8-K/A Amended current report
Acquisition or sale of assets, Unregistered share sale
Feb 3, 2016 Feb 3, 2016
8-K Current report
Material agreement, Unregistered share sale, Officer or director change
Nov 23, 2015 Nov 23, 2015
8-K Current report
Officer or director change
Nov 18, 2015 Nov 18, 2015
8-K Current report
Material agreement
Nov 17, 2015 Nov 17, 2015
8-K Current report
Unregistered share sale
Jul 30, 2015 Jul 24, 2015
8-K Current report
Bylaw or fiscal year change, Other events
Apr 17, 2015 Apr 7, 2015
8-K Current report
Material agreement, Unregistered share sale
Mar 26, 2015 Mar 19, 2015
8-K Current report
Officer or director change
Feb 10, 2015 Feb 5, 2015
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Oct 9, 2014 Sep 26, 2014
8-K Current report
Officer or director change
Jul 28, 2014 Jul 24, 2014
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jun 4, 2014 Jun 3, 2014
8-K Current report
Auditor change
Mar 18, 2014 Mar 5, 2014
8-K Current report
Officer or director change
Sep 6, 2011 Aug 30, 2011
8-K Current report
Material agreement, Unregistered share sale
Aug 29, 2011 Aug 15, 2011
8-K Current report
Officer or director change
Apr 8, 2011 Mar 30, 2011
8-K Current report
Officer or director change
Dec 7, 2010 Dec 6, 2010
8-K Current report
Material agreement, Unregistered share sale
Aug 12, 2010 Jul 30, 2010
8-K Current report
Officer or director change
Jun 22, 2010 Jun 16, 2010
8-K/A Amended current report
Unregistered share sale, Officer or director change
Jun 8, 2010 May 28, 2010
8-K Current report
Unregistered share sale, Officer or director change
Jun 1, 2010 May 28, 2010

Showing 141 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
BETRF (OTC)
Fiscal year ends
January 31
Incorporated in
British Columbia, Canada
Headquarters
Vancouver, British Columbia, Canada
SEC filer status
Non-accelerated filer
SEC CIK
1464165
Former names
Pivot Pharmaceuticals Inc. (until Dec 3, 2019); Neurokine Pharmaceuticals Inc. (until Mar 26, 2015)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.